Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

A novel approach to perform linear discriminant analyses for a 4-way alzheimer's disease diagnosis based on an integration of pearson's correlation coefficients and empirical cumulative distribution function

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

High Dimensional Classification for Spatially Dependent Data with Application to Neuroimaging

L2,p-norm and Sample Constraint Based Feature Selection and Classification for AD Diagnosis

Multivariate Deep Learning Classification of Alzheimer’s Disease Based on Hierarchical Partner Matching Independent Component Analysis

Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype

Recognition of Alzheimer's disease and Mild Cognitive Impairment with multimodal image-derived biomarkers and Multiple Kernel Learning

Classification of Alzheimer’s disease progression based on sMRI using gray matter volume and lateralization index

Diagnosis of Alzheimer’s Disease by Canonical Correlation Analysis Based Fusion of Multi-Modal Medical Images

Sparse Bayesian Multiview Learning for Simultaneous Association Discovery and Diagnosis of Alzheimer's Disease.

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

High-Order Laplacian Regularized Low-Rank Representation for Multimodal Dementia Diagnosis

A robust framework for Alzheimer's disease detection and staging: incorporating multi-feature integration, MRMR feature selection, and Random Forest classification

Computer-Aided Diagnosis System of Alzheimer's Disease Based on Multimodal Fusion: Tissue Quantification Based on the Hybrid Fuzzy-Genetic-Possibilistic Model and Discriminative Classification Based on the SVDD Model

Nonlinearity-aware Based Dimensionality Reduction and Over-Sampling for AD/MCI Classification from MRI Measures.

Disentangling brain heterogeneity via semi‐supervised deep‐learning and MRI: Application to dimensional representations of Alzheimer’s disease

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

Region-of-Interest Based Sparse Feature Learning Method for Alzheimer's Disease Identification

3D CNN-based classification using sMRI and MD-DTI images for Alzheimer disease studies

Interpretable discriminant analysis for functional data supported on random nonlinear domains with an application to Alzheimer's disease

Supervised machine learning for diagnostic classification from large-scale neuroimaging datasets